US2013274196A1PendingUtilityA1

Method for treatment of inflammatory disease and disorder

38
Assignee: HEALOR LTDPriority: Jan 11, 2010Filed: Dec 10, 2012Published: Oct 17, 2013
Est. expiryJan 11, 2030(~3.5 yrs left)· nominal 20-yr term from priority
Inventors:Liora Braiman-WiksmanTamar TennenbaumYuval SagivMarina GartsbeinEphraim BrenerMoshe Ben-HamoLiat Hammer
A61P 37/06A61P 5/14A61P 37/08A61P 37/02A61P 3/10A61P 25/00A61P 27/02A61P 29/00A61P 19/02A61K 38/10A61K 38/4866A61P 13/12C12N 9/12A61P 1/16A61P 21/04A61P 1/00A61P 17/04A61P 17/00C12Y 207/11013A61P 11/06A61P 1/04A61P 17/08A61P 11/00A61K 38/08A61P 17/06C07K 14/4703
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides a method, composition and kit for treatment of inflammatory disease and disorder using PKC isoform modulators.

Claims

exact text as granted — not AI-modified
1 . A method of treating an inflammatory disease or disorder in a subject comprising, administering to the subject an inhibitor of PKC, thereby treating the inflammatory disease or disorder in the subject. 
     
     
         2 - 33 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.